7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-09-30 2018-06-30 2018-03-31 2017-09-30 2017-06-30 2017-03-31 2016-09-30 2016-06-30 2016-03-31 2015-09-30 2015-06-30 2015-03-31 2014-09-30 2014-06-30 2014-03-31 2013-09-30 2013-06-30 2013-03-31 2012-09-30 2012-06-30 2012-03-31 2011-09-30 2011-06-30 2011-03-31 2010-09-30 2010-06-30 2010-03-31 
      
    		                                                      
      cash flow from (used in) operating activities:
    		                                                      
      net earnings
    		1,644,000,000 1,779,000,000 1,325,000,000 9,229,000,000 1,646,000,000 1,302,000,000 1,225,000,000 1,594,000,000 1,436,000,000 1,375,000,000 1,318,000,000 1,033,000,000 1,435,000,000 2,018,000,000 2,447,000,000 1,989,000,000 2,100,000,000 1,189,000,000 1,793,000,000 2,162,000,000 1,232,000,000 537,000,000 564,000,000 1,049,000,000 960,000,000 1,006,000,000 672,000,000 563,000,000 733,000,000 418,000,000 603,000,000 283,000,000 419,000,000 -329,000,000 615,000,000 316,000,000 580,000,000 784,000,000 2,292,000,000 539,000,000 466,000,000 375,000,000 965,733,000 476,055,000 544,661,000 1,942,803,000 1,724,612,000 1,242,124,000 303,181,000 1,942,782,000 863,818,000 890,660,000 1,291,650,000 1,003,015,000 
      adjustments to reconcile net earnings to net cash from operating activities —
    		                                                      
      depreciation
    		371,000,000 357,000,000 336,000,000 342,000,000 331,000,000 334,000,000 333,000,000 332,000,000 328,000,000 302,000,000 315,000,000 311,000,000 317,000,000 315,000,000 311,000,000 369,000,000 327,000,000 370,000,000 425,000,000 358,000,000 298,000,000 272,000,000 267,000,000 273,000,000 270,000,000 268,000,000 267,000,000 269,000,000 288,000,000 268,000,000 255,000,000 256,000,000 252,000,000 200,000,000 202,000,000 203,000,000 232,000,000 201,000,000 215,000,000 226,000,000 239,000,000 224,000,000 239,939,000 238,938,000 221,431,000 430,344,000 320,886,000 354,211,000 420,712,000 379,366,000 354,120,000 313,158,000 303,812,000 287,249,000 
      amortization of intangible assets
    		420,000,000 420,000,000 420,000,000 465,000,000 470,000,000 471,000,000 472,000,000 481,000,000 496,000,000 498,000,000 491,000,000 496,000,000 498,000,000 507,000,000 512,000,000 514,000,000 520,000,000 504,000,000 509,000,000 508,000,000 510,000,000 553,000,000 561,000,000 483,000,000 484,000,000 483,000,000 486,000,000 544,000,000 562,000,000 584,000,000 501,000,000 392,000,000 522,000,000 140,000,000 145,000,000 144,000,000                363,866,000   
      share-based compensation
    		120,000,000 142,000,000 289,000,000 111,000,000 117,000,000 141,000,000 304,000,000 114,000,000 117,000,000 132,000,000 281,000,000 115,000,000 123,000,000 142,000,000 305,000,000 106,000,000 114,000,000 132,000,000 288,000,000 98,000,000 100,000,000 115,000,000 233,000,000 85,000,000 94,000,000 114,000,000 226,000,000 83,000,000 101,000,000 212,000,000 75,000,000 92,000,000 171,000,000 49,000,000 62,000,000 152,000,000 44,000,000 57,000,000 148,000,000 40,000,000 49,000,000 119,000,000 44,758,000 51,548,000 125,746,000 75,608,000 85,785,000 197,342,000 67,838,000 76,457,000 175,808,000 72,146,000 84,224,000 173,866,000 
      trade receivables
    		-202,000,000 -410,000,000 -262,000,000 -158,000,000 -57,000,000 -325,000,000 -151,000,000 68,000,000 -461,000,000 -196,000,000 233,000,000 341,000,000 530,000,000 -188,000,000 -751,000,000 -189,000,000 -394,000,000 35,000,000 165,000,000 -581,000,000 -470,000,000 231,000,000 -104,000,000 82,000,000 -22,000,000        30,000,000         82,000,000    -54,220,000 611,030,000 132,482,000 -243,358,000 216,935,000 298,953,000 230,374,000 -45,803,000 291,638,000 
      inventories
    		213,000,000 3,000,000 -255,000,000 235,000,000 220,000,000 -103,000,000 -410,000,000 295,000,000 140,000,000 -248,000,000 -419,000,000 -189,000,000 -194,000,000 -476,000,000 -554,000,000 15,000,000 71,000,000 -5,000,000 -537,000,000 345,000,000 149,000,000 -550,000,000 -437,000,000 137,000,000 -190,000,000                        -2,458,000 5,195,000 44,784,000    
      other
    		221,000,000 -244,000,000 -436,000,000 639,000,000 -22,000,000 140,000,000 -748,000,000 1,937,000,000 -179,000,000 -660,000,000 -1,076,000,000 64,000,000 71,000,000 92,000,000 -205,000,000 166,000,000 -37,000,000 -97,000,000 -6,000,000 -23,000,000 247,000,000 164,000,000 -369,000,000 550,000,000 352,000,000 -890,000,000 15,000,000 578,000,000 -12,000,000 42,000,000 512,000,000 -51,000,000 101,000,000 6,000,000   234,000,000 71,000,000 230,000,000 45,000,000 0 27,000,000    -10,310,000 1,159,000 11,149,000 1,138,458,000 4,566,000 7,804,000    
      net cash from operating activities
    		2,787,000,000 2,047,000,000 1,417,000,000 2,868,000,000 2,705,000,000 1,960,000,000 1,025,000,000 3,038,000,000 1,877,000,000 1,203,000,000 1,143,000,000 2,326,000,000 2,780,000,000 2,410,000,000 2,065,000,000 3,067,000,000 2,701,000,000 2,128,000,000 2,637,000,000 3,798,000,000 2,066,000,000 1,322,000,000 715,000,000 2,416,000,000 1,948,000,000 1,060,000,000 712,000,000 2,183,000,000 1,244,000,000 1,108,000,000 2,005,000,000 1,351,000,000 574,000,000 1,217,000,000   1,195,000,000 941,000,000 2,000,000 1,201,000,000 900,000,000 336,000,000 522,125,000 716,559,000 460,255,000 3,519,502,000 2,066,829,000 2,224,930,000 3,054,430,000 2,503,152,000 2,011,146,000 2,548,413,000 2,348,297,000 1,522,752,000 
      capex
    		-496,000,000 -502,000,000 -484,000,000 -720,000,000 -556,000,000 -533,000,000 -398,000,000 -755,000,000 -560,000,000 -507,000,000 -380,000,000 -610,000,000 -467,000,000 -379,000,000 -321,000,000 -614,000,000 -461,000,000 -413,000,000 -397,000,000 -679,000,000 -496,000,000 -642,000,000 -360,000,000 -434,000,000 -401,000,000 0 0 0 0 0 0 0 0 0   0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
      free cash flows
    		2,291,000,000 1,545,000,000 933,000,000 2,148,000,000 2,149,000,000 1,427,000,000 627,000,000 2,283,000,000 1,317,000,000 696,000,000 763,000,000 1,716,000,000 2,313,000,000 2,031,000,000 1,744,000,000 2,453,000,000 2,240,000,000 1,715,000,000 2,240,000,000 3,119,000,000 1,570,000,000 680,000,000 355,000,000 1,982,000,000 1,547,000,000 1,060,000,000 712,000,000 2,183,000,000 1,244,000,000 1,108,000,000 2,005,000,000 1,351,000,000 574,000,000 1,217,000,000   1,195,000,000 941,000,000 2,000,000 1,201,000,000 900,000,000 336,000,000 522,125,000 716,559,000 460,255,000 3,519,502,000 2,066,829,000 2,224,930,000 3,054,430,000 2,503,152,000 2,011,146,000 2,548,413,000 2,348,297,000 1,522,752,000 
      cash flow from (used in) investing activities:
    		                                                      
      acquisitions of property and equipment
    		-496,000,000 -502,000,000 -484,000,000 -720,000,000 -556,000,000 -533,000,000 -398,000,000 -755,000,000 -560,000,000 -507,000,000 -380,000,000 -610,000,000 -467,000,000 -379,000,000 -321,000,000 -614,000,000 -461,000,000 -413,000,000 -397,000,000 -679,000,000 -496,000,000 -642,000,000 -360,000,000 -434,000,000 -401,000,000                              
      acquisitions of businesses and technologies, net of cash acquired
    		-55,000,000       0 -51,000,000       0 -172,000,000 0 -15,000,000 -10,000,000 0   1,000,000 -11,000,000                              
      proceeds from business dispositions
    		   0 0   0 0   0 0   0 86,000,000   10,000,000 0   0 0   0   -29,000,000                        
      sales (purchases) of other investment securities
    		90,000,000 -52,000,000 8,000,000  -40,000,000 77,000,000 -28,000,000  -38,000,000 79,000,000 -86,000,000  -21,000,000 59,000,000 -41,000,000  -108,000,000 95,000,000 -14,000,000  17,000,000 4,000,000 -36,000,000  -24,000,000 0 2,000,000                            
      net cash from investing activities
    		-457,000,000 -582,000,000 -470,000,000 -866,000,000 -594,000,000 -453,000,000 -425,000,000 -824,000,000 -634,000,000 -1,213,000,000 -462,000,000 -632,000,000 -484,000,000                       226,000,000                   
      cash flow from (used in) financing activities:
    		                                                      
      net borrowings (repayments) of short-term debt and other
    		8,000,000 -16,000,000 -36,000,000  44,000,000 -43,000,000 -127,000,000  -61,000,000 13,000,000 -42,000,000  24,000,000 5,000,000 8,000,000  -27,000,000 -4,000,000 24,000,000  -28,000,000 -20,000,000 51,000,000  12,000,000 27,000,000 13,000,000 -118,000,000                           
      proceeds from issuance of long-term debt
    		0 2,000,000 1,000,000  1,000,000    0    1,000,000        1,000,000                               0   
      repayments of long-term debt
    		-501,000,000 -1,000,000 -1,001,000,000  -2,000,000    -1,445,000,000    -1,000,000 -1,000,000 -751,000,000  -40,000,000 -3,000,000 -2,000,000  -1,330,000,000 -1,000,000 -1,000,000  -2,000,000                              
      purchases of common shares
    		-305,000,000 -6,000,000 -280,000,000 -315,000,000 -751,000,000 -3,000,000 -226,000,000 -259,000,000 -2,000,000 -426,000,000 -540,000,000 -685,000,000 -798,000,000 -5,000,000 -2,307,000,000 -974,000,000 -579,000,000 -471,000,000 -275,000,000 -161,000,000 -2,000,000 -4,000,000 -236,000,000 -496,000,000 -1,000,000                              
      proceeds from stock options exercised
    		69,000,000 35,000,000 287,000,000 25,000,000 92,000,000 13,000,000 134,000,000 34,000,000 56,000,000 15,000,000 62,000,000 41,000,000 57,000,000 10,000,000 59,000,000 82,000,000 70,000,000 17,000,000 86,000,000 16,000,000 83,000,000 57,000,000 89,000,000 7,000,000 47,000,000 117,000,000 127,000,000 74,000,000 33,000,000 137,000,000 89,000,000 57,000,000 129,000,000                      
      dividends paid
    		-1,031,000,000 -1,029,000,000 -1,026,000,000 -958,000,000 -960,000,000 -961,000,000 -957,000,000 -888,000,000 -888,000,000 -890,000,000 -890,000,000 -823,000,000 -826,000,000 -828,000,000 -832,000,000 -798,000,000 -801,000,000 -803,000,000 -800,000,000 -641,000,000 -639,000,000 -642,000,000 -638,000,000 -568,000,000 -569,000,000                              
      net cash from financing activities
    		-1,760,000,000 -1,097,000,000 -2,055,000,000 -1,861,000,000 -1,576,000,000 -791,000,000 -1,176,000,000 -2,052,000,000 -2,340,000,000 -1,289,000,000 -1,410,000,000 -1,457,000,000 -1,543,000,000                                  115,367,000 286,074,000       
      effect of exchange rate changes on cash and cash equivalents
    		-10,000,000 51,000,000 24,000,000 -83,000,000 36,000,000 -13,000,000 -36,000,000 25,000,000 -29,000,000 -27,000,000 8,000,000 51,000,000 -96,000,000 -71,000,000 -6,000,000 -13,000,000 -29,000,000 4,000,000 -32,000,000 78,000,000 38,000,000 25,000,000 -70,000,000 27,000,000 -49,000,000 2,000,000 4,000,000   35,000,000 24,000,000 8,000,000 65,000,000               34,700,000  14,298,000 66,203,000    
      net increase in cash and cash equivalents
    		560,000,000 419,000,000 -1,084,000,000 58,000,000 571,000,000 703,000,000 -612,000,000 187,000,000 -1,126,000,000 -1,326,000,000 -721,000,000 288,000,000 657,000,000 1,262,000,000 -2,124,000,000 497,000,000 644,000,000 604,000,000 1,216,000,000 2,358,000,000 -283,000,000   -231,000,000                43,000,000      944,172,000   972,281,000      
      cash and cash equivalents, beginning of year
    		0 0 7,616,000,000 0 0 0 6,896,000,000 0 0 0 9,882,000,000 0 0 0 9,799,000,000 0 0 0 6,838,000,000 0 0 0 3,860,000,000 0 0 0 3,844,000,000 0 0 9,407,000,000 0 0 18,620,000,000 0 0 5,001,000,000 0 0 4,063,000,000 0 0 3,475,000,000 0 0 10,802,163,000 0 0 6,812,820,000 0 0 3,648,371,000 0 0 8,809,339,000 
      cash and cash equivalents, end of period
    		560,000,000 419,000,000 6,532,000,000  571,000,000 703,000,000 6,284,000,000  -1,126,000,000 -1,326,000,000 9,161,000,000  657,000,000 1,262,000,000 7,675,000,000  644,000,000 604,000,000 8,054,000,000  -283,000,000 1,386,000,000 3,377,000,000  954,000,000 115,000,000 3,022,000,000 4,304,000,000 -792,000,000 3,857,000,000 1,337,000,000 969,000,000 8,706,000,000 -78,000,000 -756,000,000 3,334,000,000 -916,000,000 822,000,000 3,226,000,000 43,000,000 1,510,000,000 2,060,000,000 -2,689,800,000 1,199,134,000 4,373,120,000 944,172,000 2,706,866,000 4,345,910,000 972,281,000 1,336,862,000 2,740,156,000 -503,557,000 2,754,882,000 1,566,820,000 
      adjustments to reconcile earnings to net cash from operating activities —
    		                                                      
      investing and financing losses
    		                                                      
      prepaid expenses and other assets
    		                                                      
      trade accounts payable and other liabilities
    		                                                      
      income taxes
    		                                                      
      purchases of investment securities
    		                                                      
      proceeds from sales of investment securities
    		                                                     874,139,000 
      proceeds from issuance of (repayments of) short-term debt, net and other
    		                                                      
      proceeds from issuance of long-term debt and debt with maturities over 3 months
    		                                                      
      repayments of long-term debt and debt with maturities over 3 months
    		                                                      
      cash and cash equivalents, end of year
    		                                                      
      supplemental cash flow information:
    		                                                      
      income taxes paid
    		                                                      
      interest paid
    		                                                      
      ​
    		                                                      
      net cash (used in) investing activities
    		              -360,000,000  -651,000,000 -264,000,000 -422,000,000  -472,000,000 -619,000,000 -393,000,000  -432,000,000                              
      net cash (used in) financing activities
    		              -3,823,000,000  -1,377,000,000 -1,264,000,000 -967,000,000  -1,915,000,000 658,000,000 -735,000,000  -513,000,000                              
      loss on extinguishment of debt
    		                                                      
      adjustments to reconcile net earnings to net cash from operating activities-
    		                                                      
      adjustments to reconcile earnings to net cash from operating activities -
    		                                                      
      amortization of inventory step-up
    		                           0 0 32,000,000 18,000,000 430,000,000 392,000,000                      
      adjustments to reconcile net earnings to net cash from operating activities -
    		                                                      
      net decrease in cash and cash equivalents
    		                      -483,000,000                                
      amortization of bridge financing fees
    		                                                      
      gains on sale of businesses
    		                                                      
      gain on sale of mylan n.v. shares
    		                                                      
      proceeds from the sale of mylan n.v. shares
    		                              53,000,000 239,000,000 1,685,000,000                      
      purchase of alere preferred stock
    		                                                      
      acquisition and contingent consideration payments related to business acquisitions
    		                                                      
      gain on sale of businesses
    		                                                      
      payment of debt issuance costs
    		                                                      
      payment of contingent consideration
    		                                                      
      proceeds from business disposition
    		                                5,472,000,000 0 0 25,000,000 0 0 230,000,000                
      sales (purchases) of investment securities
    		                                   446,000,000    2,239,000,000               
      net proceeds (repayments of) short-term debt and other
    		                             6,000,000                         
      impact of currency devaluation
    		                                 4,000,000 0 477,000,000                   
      mylan n.v. equity investment adjustment
    		                                                      
      net (repayments of) short-term debt and other
    		                                                      
      gain on sale of discontinued operations
    		                                                      
      net (repayments of) proceeds from issuance of short-term debt and other
    		                                                      
      proceeds from the issuance of long-term debt
    		                                    0 0 2,485,000,000                
      proceeds from stock options exercised, including income tax benefit
    		                                 76,000,000 43,000,000 87,000,000 50,000,000 57,000,000 156,000,000 64,000,000 56,000,000 170,000,000 37,656,000 73,641,000 68,963,000 524,093,000 359,039,000 687,279,000 47,808,000 93,903,000 175,752,000   188,169,000 
      gain on sale of mylan shares
    		                                                      
      proceeds from the sale of mylan shares
    		                                                      
      net cash (used in) from investing activities
    		                                                      
      net cash (used in) from operating activities
    		                                                      
      amortization of intangibles
    		                                    151,000,000 151,000,000 156,000,000 129,000,000 161,000,000 174,000,000 196,753,000 196,892,000 199,422,000 329,384,000 370,549,000 389,056,000 417,674,000 432,046,000 391,547,000   275,252,000 
      (purchases) sales of other investment securities
    		                                                      
      net (repayments of ) proceeds from issuance of short-term debt and other
    		                                                      
      contingent and other consideration payments related to business acquisitions
    		                                                      
      net (repayments of) proceeds from short-term debt and other
    		                                                      
      acquisitions of business and technology
    		                                                      
      proceeds from issuance of short-term debt and other
    		                                       397,000,000 -341,000,000 1,213,000,000 374,281,000 901,226,000 2,248,631,000  1,297,740,000 1,399,029,000   396,213,000   775,006,000 
      transfer of cash and cash equivalents to abbvie inc.
    		                                                      
      acquired in-process and collaborations research and development
    		                                             0 110,000,000 150,000,000       
      acquisitions of businesses and technology
    		                                                      
      payment of long-term debt
    		                                                      
      contingent consideration payment related to a business acquisition
    		                                                      
      net cash (used in) from financing activities
    		                                                      
      acquisition of businesses and technology
    		                                                      
      release of restricted funds
    		                                                      
      proceeds from issuance of (repayments of) short-term debt and other
    		                                                      
      acquired in-process research and development
    		                                                0 172,500,000 100,000,000    
      (purchases of) proceeds from sales of investment securities
    		                                                      
      release of (deposit of) restricted funds
    		                                                0      
      repayments of short-term debt and other
    		                                                      
      acquisitions of businesses, net of cash acquired
    		                                                      
      deposit of restricted funds
    		                                                      
      net (decrease) in cash and cash equivalents
    		                                                      
      derecognition of a contingent liability associated with the conclusion of the tap pharmaceutical products inc. joint venture
    		                                                      
      proceeds from sales of (purchases of) investment securities
    		                                                   14,317,000   
      (repayments of) proceeds from issuance of short-term debt and other
    		                                                      
      payments of long-term debt
    		                                                      
      proceeds from stock options exercised, including tax benefit
    		                                                   68,457,000   
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.